Matches in DBpedia 2016-04 for { ?s ?p "Mazapertine (RWJ-37796) is an antipsychotic agent that was developed by Johnson & Johnson but never marketed. It exerts its pharmacological effect through affinity for dopamine D2, serotonin 5-HT1A, and α1-adrenergic receptors.Mazapertine is safe and well tolerated when administered orally.Analogs of mazapertine with conformational restriction have been prepared and have greater affinity for the 5-HT1A receptor."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Mazapertine abstract "Mazapertine (RWJ-37796) is an antipsychotic agent that was developed by Johnson & Johnson but never marketed. It exerts its pharmacological effect through affinity for dopamine D2, serotonin 5-HT1A, and α1-adrenergic receptors.Mazapertine is safe and well tolerated when administered orally.Analogs of mazapertine with conformational restriction have been prepared and have greater affinity for the 5-HT1A receptor.".
- Q15426196 abstract "Mazapertine (RWJ-37796) is an antipsychotic agent that was developed by Johnson & Johnson but never marketed. It exerts its pharmacological effect through affinity for dopamine D2, serotonin 5-HT1A, and α1-adrenergic receptors.Mazapertine is safe and well tolerated when administered orally.Analogs of mazapertine with conformational restriction have been prepared and have greater affinity for the 5-HT1A receptor.".
- Mazapertine comment "Mazapertine (RWJ-37796) is an antipsychotic agent that was developed by Johnson & Johnson but never marketed. It exerts its pharmacological effect through affinity for dopamine D2, serotonin 5-HT1A, and α1-adrenergic receptors.Mazapertine is safe and well tolerated when administered orally.Analogs of mazapertine with conformational restriction have been prepared and have greater affinity for the 5-HT1A receptor.".
- Q15426196 comment "Mazapertine (RWJ-37796) is an antipsychotic agent that was developed by Johnson & Johnson but never marketed. It exerts its pharmacological effect through affinity for dopamine D2, serotonin 5-HT1A, and α1-adrenergic receptors.Mazapertine is safe and well tolerated when administered orally.Analogs of mazapertine with conformational restriction have been prepared and have greater affinity for the 5-HT1A receptor.".